Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 1,284 | 1,180 | 1,357 | 1,268 | 1,117 |
| Gross Profit | 1,284 | 1,180 | 1,357 | 1,268 | 1,117 |
| Operating Expenses | 3,725 | 3,759 | 2,876 | 2,503 | 3,101 |
| Operating Income | -2,441 | -2,579 | -1,519 | -1,235 | -1,984 |
| Other Income | 49 | 29 | 54 | 220 | 54 |
| Pre-tax Income | -2,392 | -2,550 | -1,465 | -1,015 | -1,930 |
| Net Income Continuous | -2,392 | -2,550 | -1,465 | -1,015 | -1,930 |
| Net Income Discontinuous | -52 | -49 | 86 | -43 | -30 |
| Net Income | $-2,444 | $-2,599 | $-1,379 | $-1,058 | $-1,960 |
| EPS Basic Total Ops | -9.60 | -10.40 | -4.93 | -4.00 | -8.00 |
| EPS Basic Continuous Ops | -8.80 | -9.60 | -5.60 | -4.00 | -7.20 |
| EPS Basic Discontinuous Ops | -0.20 | -0.19 | 0.31 | -0.17 | -0.12 |
| EPS Diluted Total Ops | -9.60 | -10.40 | -4.93 | -4.00 | -8.00 |
| EPS Diluted Continuous Ops | -8.80 | -9.60 | -5.60 | -4.00 | -7.20 |
| EPS Diluted Discontinuous Ops | -0.20 | -0.19 | 0.32 | -0.17 | -0.12 |
| EBITDA(a) | $-2,346 | $-2,530 | $-1,251 | $-1,085 | $-1,843 |